Genomic Health Inc (GHDX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Kimberly J. Popovits
Employees:
829
301 PENOBSCOT DRIVE, REDWOOD CITY, CA 94063
650-556-9300

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Genomic Health, Inc. engages in the development and global commercialization of genomic- based clinical laboratory services that analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. Its uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Data derived from most recent annual or quarterly report
Market Cap 2.366 Billion Shares Outstanding37.29 Million Avg 30-day Volume 1.072 Million
P/E Ratio46.689 Dividend Yield0.0 EPS1.28
Price to Revenue5.9794 Debt to Equity0.0 EBITDA67.999 Million
Price to Book Value7.5625 Operating Margin12.5622 Enterprise Value2.367 Billion
Current Ratio5.959 EPS Growth2.02 Quick Ratio5.722
1 Yr BETA 1.2543 52-week High/Low 0.0 / Profit Margin12.8068
Operating Cash Flow Growth49.6302 Altman Z-Score15.8039 Free Cash Flow to Firm 43.147 Million
View SEC Filings from GHDX instead.

View recent insider trading info

Funds Holding GHDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GHDX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-11-07:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-10-28:
    Item 8.01: Other Events
  • 8-K: filed on 2019-09-11:
    Item 8.01: Other Events
  • 8-K: filed on 2019-07-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-29:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2019-02-01:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    EXACT SCIENCES CORP

    • 10% Owner
    • SEE FOOTNOTES
    100 2019-11-08 0

    GRAHAM GINGER L

    • Director
    No longer subject to file 2019-11-08 0

    FUCHS HENRY J

    • Director
    No longer subject to file 2019-11-08 0

    POPOVITS KIMBERLY J PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2019-11-08 0

    SHAK STEVEN CHIEF SCIENTIFIC OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    COLE G BRADLEY CFO

    • Officer
    No longer subject to file 2019-11-08 0

    COHEN FRED E

    • Director
    No longer subject to file 2019-11-08 0

    PARKER GEOFFREY M.

    • Director
    No longer subject to file 2019-11-08 0

    FLANNELLY BARRY P

    • Director
    No longer subject to file 2019-11-08 0

    PLA FREDERIC COO

    • Officer
    No longer subject to file 2019-11-08 0

    LEBER LAURA CHIEF COMMUNICATION OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    MCEACHRON KIM CHIEF PEOPLE OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    RADFORD JASON W. CHIEF LEGAL OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    VAUGHN JAMES J CHIEF COMMERCIAL OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    HOOF TORSTEN CHIEF INT'L COMMERCIAL OFFICER

    • Officer
    No longer subject to file 2019-11-08 0

    BAKER BROS. ADVISORS LP

    14159, L.P.

    667, L.P.

    BAKER BROS. ADVISORS (GP) LLC

    BAKER BROTHERS LIFE SCIENCES LP

    BAKER FELIX

    BAKER JULIAN

    BAKER BROS. INVESTMENTS, L.P.

    BAKER/TISCH INVESTMENTS, LP

    • Director
    • 10% Owner
    9,430,119 2019-10-01 0

    BAKER BROS. ADVISORS LP

    BAKER BROS. INVESTMENTS II, L.P.

    BAKER BROS. INVESTMENTS, L.P.

    BAKER/TISCH INVESTMENTS, LP

    14159, L.P.

    667, L.P.

    BAKER BROS. ADVISORS (GP) LLC

    BAKER BROTHERS LIFE SCIENCES LP

    BAKER FELIX

    BAKER JULIAN

    • Director
    • 10% Owner
    9,471,630 2019-08-29 0

    BAKER BROS. ADVISORS LP

    BAKER BROTHERS LIFE SCIENCES LP

    BAKER FELIX

    BAKER JULIAN

    BAKER BROS. ADVISORS LP

    BAKER BROS. INVESTMENTS II, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    BAKER BROS. INVESTMENTS, L.P.

    BAKER FELIX

    BAKER JULIAN

    BAKER/TISCH INVESTMENTS, LP

    BAKER BROS. INVESTMENTS II, L.P.

    14159, L.P.

    BAKER BROS. INVESTMENTS, L.P.

    667, L.P.

    BAKER/TISCH INVESTMENTS, LP

    BAKER BROS. ADVISORS (GP) LLC

    14159, L.P.

    667, L.P.

    BAKER BROS. ADVISORS (GP) LLC

    • Director
    • 10% Owner
    13,494,075 2018-11-16 0

    FEBBO PHILLIP G. CHIEF MEDICAL OFFICER

    • Officer
    21,387 2018-02-20 0

    LIVINGSTON RANDALL S

    • Director
    0 2016-06-10 0

    COLELLA SAMUEL D

    • Director
    59,653 2014-10-01 0

    SCHORNO DEAN L CFO

    • Officer
    51,825 2014-06-10 0

    HIBBS KATHY L SVP & GENERAL COUNSEL

    • Officer
    15,787 2014-02-15 0

    MYERS WOODROW A JR

    • Director
    3,880 2013-10-01 0

    BAKER BROS. ADVISORS (GP) LLC

    • Director
    • 10% Owner
    0 2013-07-01 0

    BAKER FELIX

    BAKER BROS. INVESTMENTS, L.P.

    BAKER BROS. INVESTMENTS II, L.P.

    BAKER/TISCH INVESTMENTS, LP

    667, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    14159, L.P.

    BAKER BROS ADVISORS LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    16,500 2013-06-07 0

    BAKER FELIX

    BAKER JULIAN

    BAKER BROTHERS LIFE SCIENCES LP

    14159, L.P.

    667, L.P.

    BAKER BROS ADVISORS LLC

    • Director
    • 10% Owner
    13,273,646 2013-06-04 0

    BAKER FELIX

    BAKER BROS. INVESTMENTS, L.P.

    BAKER BROS. INVESTMENTS II, L.P.

    BAKER/TISCH INVESTMENTS, LP

    667, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    14159, L.P.

    • Director
    • 10% Owner
    12,537,654 2013-01-01 0

    BAKER FELIX

    • Director
    • 10% Owner
    11,377,773 2012-10-01 0

    BAKER BROTHERS LIFE SCIENCES LP

    • Director
    9,086,690 2012-07-26 0

    FBB ASSOCIATES

    • Director
    173,897 2012-07-26 0

    BAKER BROS. INVESTMENTS II, L.P.

    • Director
    13,238 2012-07-26 0

    BAKER BROS. INVESTMENTS, L.P.

    • Director
    173,897 2012-07-26 0

    BAKER/TISCH INVESTMENTS, LP

    • Director
    194,161 2012-07-26 0

    14159, L.P.

    • Director
    247,063 2012-07-26 0

    667, L.P.

    • Director
    1,488,539 2012-07-26 0

    SCOTT RANDAL W CEO, INVITAE CORPORATION*

    • Officer
    • Director
    2,400,998 2012-07-10 0

    BAKER JULIAN

    • Director
    0 2012-06-08 0

    BAKER JULIAN

    BAKER BROS ADVISORS LLC

    BAKER FELIX

    • Director
    • 10% Owner
    9,333,753 2012-05-21 0

    BAKER BROS ADVISORS LLC

    • Director
    • 10% Owner
    0 2012-04-12 0

    BAKER BIOTECH CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    1,484,977 2012-03-07 0

    BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    8,255,421 2012-03-07 0

    14159 CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    227,840 2012-03-07 0

    BAKER JOFFRE CHIEF SCIENTIFIC OFFICER

    • Officer
    235,302 2012-02-15 0

    BAKER BROS. CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    187,135 2011-06-30 0

    BYERS BROOK H

    • Director
    24,357 2011-04-01 0

    BAKER / TISCH CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    194,161 2009-05-20 0

    GOLDBERG MICHAEL D

    • Director
    8,250 2007-06-13 0

    BAKER BIOTECH CAPITAL (GP), LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    544,384 2007-03-01 0

    BAKER BROS. CAPITAL (GP), LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    189,965 2007-03-01 0

    BAKER / TISCH CAPITAL (GP), LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    190,578 2007-03-01 0

    BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    1,569,539 2007-03-01 0

    14159 CAPITAL (GP), LLC

    BAKER JULIAN

    • Director
    • 10% Owner
    33,092 2007-03-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments